Literature DB >> 3134142

Glycosaminoglycan excretion in connective tissue diseases.

I Endreffy1, F Dicsö.   

Abstract

Abnormal glycosaminoglycan metabolism has been widely studied in cases of mucopolysaccharidoses (MPSD) with increased acid glycosaminoglycan (aGAG) excretion. A disorder in aGAG metabolism can be confirmed in several diseases with known etiology. We have carried out a comparative study on the urinary aGAG output in systemic connective tissue diseases and in childhood cases of MPSD. In children suffering from rheumatoid arthritis or scleroderma, the urinary aGAG output did not surpass 80% of the value excreted in MPSD; furthermore, 20 to 30% was uronic acid. In the case of osteogenesis imperfecta the remarkably high amount of excreted aGAG contained over 60% uronic acid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134142     DOI: 10.1016/s0009-9120(88)80103-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  1 in total

1.  Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet.

Authors:  Ildikó Endreffy; Geir Bjørklund; Ferenc Dicső; Mauricio A Urbina; Emőke Endreffy
Journal:  Metab Brain Dis       Date:  2015-10-14       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.